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Background: Velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) is caused by a 1.5-3 Mb microdeletion of
chromosome 22q11.2, frequently referred to as 22q11.2 deletion syndrome (22q11DS). This region includes TBX1, a
T-box transcription factor gene that contributes to the etiology of 22q11DS. The requirement for TBX1 in
mammalian development is dosage-sensitive, such that loss-of-function (LOF) and gain-of-function (GOF) of TBX1 in
both mice and humans results in disease relevant congenital malformations.
Results: To further gain insight into the role of Tbx1 in development, we have targeted the Rosa26 locus to
generate a new GOF mouse model in which a Tbx1-GFP fusion protein is expressed conditionally using the
Cre/LoxP system. Tbx1-GFP expression is driven by the endogenous Rosa26 promoter resulting in ectopic and
persistent expression. Tbx1 is pivotal for proper ear and heart development; ectopic activation of Tbx1-GFP in the
otic vesicle by Pax2-Cre and Foxg1-Cre represses neurogenesis and produces morphological defects of the inner ear.
Overexpression of a single copy of Tbx1-GFP using Tbx1Cre/+ was viable, while overexpression of both copies
resulted in neonatal lethality with cardiac outflow tract defects. We have partially rescued inner ear and heart
anomalies in Tbx1Cre/- null embryos by expression of Tbx1-GFP.
Conclusions: We have generated a new mouse model to conditionally overexpress a GFP-tagged Tbx1 protein
in vivo. This provides a useful tool to investigate in vivo direct downstream targets and protein binding partners
of Tbx1.
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Velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/
DGS), also known as 22q11.2 deletion syndrome (22q11DS),
is the most common microdeletion syndrome occurring de
novo in approximately 1/4,000 live births [1]. TBX1, encod-
ing a T-box transcription factor, is located within the 1.5 Mb
critically deleted region and haploinsufficiency of this gene
is responsible for the congenital defects associated with
22q11DS [2]. Tbx1 null mutant mice have malformations
of the heart, thymus/parathyroid, craniofacial region, and
ear that are similar but more severe, to what is typically
found in 22q11DS patients [2-4]. Previously generated
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reproduction in any medium, provided the orhuman TBX1 also have developmental defects of the same
tissues affected in Tbx1−/− null mice, resembling clinical
features of a recently identified 22q11 duplication syn-
drome [5-9]. Ablation studies using Tbx1flox conditional
null mutants have proven to be indispensible for under-
standing the tissue and cell-type specific roles of the Tbx1
gene [10,11]. COET, a transgenic mouse line with condi-
tional overexpression of Tbx1, has previously been
reported [12]. However, the COET mouse line does not
contain a protein affinity tag on the Tbx1 protein. We
have generated a conditional allele targeted at the Rosa26
locus for the purpose of expressing additional copies of
Tbx1 fused to a GFP reporter in a tissue-specific manner.
We chose a GFP tag in part to detect live GFP as a read-
out for activation of Tbx1-GFP in vivo and to use it for fu-
ture biochemical or chromatin immunoprecipitation
experiments. Tbx1 mutant rescue experiments demon-
strate that Tbx1-GFP fusion protein functions in vivo in a
manner similar to that of endogenous Tbx1. The Tbx1-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that is targeted to the constitutively active Rosa26 locus;
targeting Tbx1-GFP to the endogenous Tbx1 locus would
simultaneously disrupt the normal function of the targeted
allele (as is the case for Tbx1Cre/+ mice, Huynh et al.,
2007). As such, our model works to activate 1–2 ectopic
copies of Tbx1 while simultaneously tracing cells with
GFP, and should therefore be of high value in future ex-
perimental studies.
Results and discussion
To generate the Tbx1-GFP allele, we first generated a
bacterial plasmid that expresses a Tbx1-GFP fusion pro-
tein of approximately 75 kilodaltons (kD) (Figure 1A),
corresponding to the combined mass of Tbx1 (~50 kD)
and GFP (~27 kD) (Figure 1B). The Tbx1-GFP fragment
was inserted downstream of a triple polyadenylation
(tpA) transcriptional stop sequence that is flanked by
LoxP sites in the pBigT vector [13]. The loxP-tpA-loxP-
Tbx1-GFP element was cloned into the pROSA26PA
vector for targeting to the Rosa26 locus [13,14], and
electroporated into WW6 (129/SvJ) mouse embryonic
stem cells (ESC). We identified 5/56 correctly targeted
ESC clones by Southern blot analysis (Figure 1C). Clone
45 was chosen for blastocyst injection in C57BL6 fe-
males to generate chimeras for germline transmission.Figure 1 Generation of the Tbx1-GFP mouse. (A) Tbx1-GFP was inserted
polyadenylation sequence (tpA) that is flanked by LoxP sites (triangles). Ad
targeting construct. 5’ and 3’ homology arms mediate recombination with
transfected (T) with Tbx1-GFP plasmid or untransfected (UT). The fusion pro
blot. (C) Southern blot was used to screen ESC clones. Genomic DNA was
binds upstream of the 5’ homology arm. Two of five positive clones are sh
is 11,517 kb.To test the Tbx1-GFP allele, we crossed Tbx1-GFPflox/flox
mice to Foxg1-Cre and Pax2-Cre mice [15,16] and ana-
lyzed their respective phenotypes. Both Cre drivers have
previously been used to inactivate Tbx1 by tissue-specific
recombination of loxP sites [11,17]. Foxg1-Cre expression
overlaps with endogenous Tbx1 expression in tissues
such as the pharyngeal apparatus and otic vesicle
(OV) [11,15,17]. In the study presented here, we show
that Foxg1-Cre can ectopically activate Tbx1-GFP in
the olfactory placode, forebrain, and optic vesicle
resulting in morphological defects of these tissues
during development (Figure 2A). In addition, by E15.5,
Foxg1-Cre;Tbx1-GFPflox/+ mutants display thymic aplasia
likely due to overexpression of Tbx1-GFP in the 3rd
pharyngeal pouch, and abnormal formation of the nasal
prominence. Pax2-Cre;Tbx1-GFPflox/+ mutants are peri-
natal lethal (Figure 2A).
Since inner ear and cardiac defects are two of the most
prominent features in the Tbx1 null mutant, we decided
to examine those structures in more detail in the Pax2-
Cre;Tbx1-GFPflox/+ mutants and Foxg1-Cre;Tbx1-GFPflox/+
mutants, respectively. Foxg1-Cre and Pax2-Cre are both
strongly expressed throughout the OV, from which the
inner ear forms. Both loss or gain of Tbx1 function
in the OV disrupts inner ear morphogenesis [5,18,19].
Paintfilling of the inner ear in Foxg1-Cre;Tbx1-GFPflox/+into the multiple cloning site (MCS) of pBigT downstream of a triple
ditional subcloning into the pROSA26PA plasmid resulted in the final
the endogenous Rosa26 locus. (B) Whole cell lysates from COS7 cells
tein is ≈75 kD and is detected by anti-GFP and anti-Tbx1 on Western
linearized with EcoRV and hybridized with a radiolabeled probe that
own. The correctly targeted allele is 4,071 bp and the wildtype allele
Figure 2 Activation of Tbx1-GFP by Foxg1-Cre and Pax2-Cre. (A) Foxg1-Cre;Tbx1-GFPflox/+ mutants have thymic aplasia and nasal
malformations at E15.5, and eye and pharyngeal defects at E11.5. (B) Pax2-Cre;Tbx1-GFPflox/+ mutants die shortly after birth. They have
microcephaly and ocular defects. Thymus (T), heart (H), lungs (L), forebrain (FB). (C) Paintfilling of inner ears in Pax2-Cre;Tbx1-GFPflox/+ and
Foxg1-Cre;Tbx1-GFPflox/+ mutants. The endolymphatic duct (ED) and common crus (CC) are enlarged. The lateral semicircular canal (LC), utricle (U),
and saccule (S) are missing. The cochlea (C) is shortened to varying degrees. BAC316.23 mice show similarities in inner ear morphological defects.
Anterior canal (AC), posterior canal (PC). (D) Wholemount RNA in situ hybridization at E9.5 for NeuroD, expressed in neuroblasts of the cranial
ganglia. Wholemount immunohistochemistry stains cranial sensory ganglia with anti-Neurofilament (NF) at E10.5. Red brackets indicate olfactory
placode. Otic vesicle is circled in yellow.
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enlarged endolymphatic duct (ED) and common crus
(CC) that joins the anterior and posterior semicircular ca-
nals (SCC) (Figure 2B). The utricle, saccule, and lateral
SCC are missing. The cochlea is hypoplastic with varying
degree, but enlarged in two instances (Figure 2B). This
phenotype is very similar to that of BAC316.23 transgenic
mice [5]; with the exception that BAC316.23 mice still
possess the lateral SCC, and in most cases the saccule and
utricle are present, albeit malformed (Figure 2B).
Tbx1 is also known to repress neurogenesis of the
VIIIth cranial ganglion that innervates the inner ear[19]. Here we show that in Foxg1-Cre;Tbx1-GFPflox/+
mutants, expression of Neurogenic differentiation factor
1 (NeuroD) is nearly abolished in the VIIIth cranial gan-
glion, and highly attenuated in cranial ganglia V, VII, IX,
and X (Figure 2C). Immunohistochemistry with anti-
Neurofilament confirmed loss of the VIIIth cranial gang-
lion and abnormal size and misguided projections from
other cranial ganglia in Foxg1-Cre;Tbx1-GFPflox/+ mu-
tants (Figure 2C). In addition, we found that NeuroD
expression is completely missing from the olfactory
placode of Foxg1-Cre;Tbx1-GFPflox/+ mutants; a region
where Foxg1-Cre is active and there is no Tbx1
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function of Tbx1 in the olfactory placode leads to ec-
topic repression of NeuroD. These findings demonstrate
that Tbx1 could act directly or indirectly on neurogenic
factors that are common to both otic and olfactory
placodes.
Examination of SCC defects in the Pax2-Cre;Tbx1-
GFPflox/+ mutants using paintfilling revealed a delay in
SCC formation at earlier developmental stages (Figure 3A).
In the wild type, clearing of the fusion plates is visible by
E12.25 and complete by E12.5 [20]. In Pax2-Cre;Tbx1-
GFPflox/+ mutants, the fusion plates have not yet joined at
E12.25 although they appear to partially recover by E14.5
(Figure 3A). Histological sections at E12.25 confirm that
the fusion plates in Pax2-Cre;Tbx1-GFPflox/+ mutants re-
main attached to the periotic mesenchyme compared to
control littermates (Figure 3A). We examined expression
of laminin and netrin-1, a secreted protein that is related
to laminins and promotes basal lamina breakdown [21,22].
We observed decreased laminin protein levels along the
otic epithelium, especially along the site of lateral SCC for-
mation along with a corresponding decrease in netrin-1
mRNA expression along the fusion plates in Pax2-Cre;
Tbx1-GFPflox/+ mutants (Figure 3B). It is possible that
Tbx1 may act to repress netrin-1, thereby modulating cellFigure 3 Altered cell adhesion properties in Tbx1 mutants. (A) Paintfill
earlier stages of development reveals a delay in SCC formation. At E12.25, f
to have formed in the mutants. Histological analysis confirms defects in the
be seen to have separated from the mesenchyme (asterisks). In Tbx1-GFP m
tissue. (B) Immunofluorescence with anti-laminin (red). Arrows indicate the
Tbx1-GFP mutants. RNA in situ hybridization to netrin-1 on sections. Netrin-1
Anterior canal (AC, lateral canal (LC). (C) Expression of netrin-1 mRNA on w
mesenchyme surrounding the inner ear in the absence of endogenous Tbxadhesion properties. Complementation of these results oc-
curred in Tbx1−/− null mice in which expression of netrin-
1 is expanded in the mesenchyme surrounding the OV
(Figure 3C). We did not observe expanded netrin-1 expres-
sion in the OV of Tbx1−/− null mice, possibly due to the
severity of the OV phenotype and subsequent absence of
vestibular structures.
To test whether Tbx1-GFP could rescue inner ear de-
fects that occur in Tbx1Cre/- null embryos, we crossed
Tbx1-GFPflox/flox mice to Tbx1Cre/+ mice [23]. Tbx1Cre/-
mice have been shown to recapitulate the Tbx1−/− null
phenotype [23]. When Cre is expressed, cells from the
Tbx1Cre/+ expressing domain are positive for GFP in a
manner that represents the Tbx1 lineage in the OV in
embryos (Figure 4A). Expression of Tbx1-GFP under the
Rosa26 promoter alone is not sufficient for direct
visualization of natural GFP, therefore Tbx1-GFP protein
was detected using an antibody to GFP. Since expression
of Tbx1-GFP is persistently driven by the endogenous
Rosa26 promoter, we expect the domain of activated
Tbx1-GFP to be more extensive than native Tbx1 expres-
sion (Figure 4A). Immunofluorescence with anti-GFP anti-
serum demonstrated that there is no Tbx1-GFP protein in
the absence of Cre expression in the OV (Figure 4A).
Tbx1Cre/+;Tbx1-GFPflox/+ mutants did not exhibit grossing of inner ears from Pax2-Cre;Tbx1-GFPflox/+ mutants at progressively
usion plates (arrows, FP) are visible in the controls, but do not appear
fusion plates (FP, red arrows). In controls, the vestibular epithelia can
utants, there is no separation of the epithelium from surrounding
span of the fusion plate epithelia. There is more intact laminin in the
expression is reduced in the fusion plates of Tbx1-GFP mutants.
ildtype and Tbx1−/− null mice. Netrin-1 expression is increased in the
1.
Figure 4 Activation of Tbx1-GFP in the inner ear using Tbx1Cre/+. (A) Immunofluorescence with GFP (red) and Tbx1 (red) antibodies on E10.5
transverse sections through the otic vesicle (OV). The VIIIth cranial ganglion, also known as the cochleovestibular ganglion (CVG) is adjacent to
the OV. Neural tube (NT). (B) Activation of Tbx1-GFP by Tbx1Cre/+ does not produce major morphological defects of the inner ear, as visualized by
paintfilling at E14.5. (C) Paintfilling shows failure of inner ear morphogenesis in Tbx1Cre/- null mice at E14.5 compared to the Tbx1-GFPflox/+ control.
Activation of a single allele of Tbx1-GFP on a Tbx1Cre/- null background is capable of partially rescuing morphogenesis.
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(Figure 4B), perhaps because one allele of Tbx1 is removed
by knock-in of Cre. Paintfilling confirmed that the inner
ears of Tbx1−/− null mice lack all discernible vestibular and
auditory structures with the exception of what appears to
be an enlarged ED (Figure 4C). When a single allele of
Tbx1-GFP is activated in a Tbx1Cre/- background, there is
rescue of the anterior and posterior SCCs in all em-
bryos, and partial rescue of the saccule and cochlea (n=6)
(Figure 4C). Complete rescue of the null phenotype is not
expected with constitutive activation of Tbx1-GFP because
temporal regulation of Tbx1 is required for normal inner
ear development.
The Tbx1Cre/+ allele was also used to activate Tbx1-
GFP in other endogenous sites of Tbx1 expression such
as the pharyngeal mesoderm including the secondary
heart field (Figure 5A). Histological analysis of Tbx1Cre/+;
Tbx1GFPflox/+ embryos at E14.5 showed normal heart de-
velopment (Figure 5B). Genotyping of mice at P10 con-
firmed presence of live Tbx1Cre/+;Tbx1GFPflox/+ mice in
normal Mendelian ratios (Figure 5B). In contrast, mice
that have both Tbx1-GFP alleles activated by Tbx1Cre/+ are
not viable (Figure 5B), prompting us to assess the heart
phenotype in Tbx1Cre/+;Tbx1GFPflox/flox embryos at E14.5.
Tbx1Cre/+;Tbx1GFPflox/flox embryos exhibited defectssuch as persistent truncus arteriosus (PTA, 2/5 embryos)
and double outlet right ventricle (DORV, 3/5 embryos),
all with ventricular septal defects (VSD, 5/5 embryos)
(Figure 5C). Overexpression of TBX1 has been previ-
ously associated with VSD in ~10% of BAC316.23
transgenic mice [2]. Heart malformations can account
for the perinatal lethality of Tbx1Cre/+;Tbx1GFPflox/flox
mice. We wanted to compare the protein expression
levels of the Tbx1-GFP fusion protein activated in the
Tbx1 domain compared to endogenous Tbx1 protein.
To do this, we performed western blot on tissue sam-
ples (Figure 5D) and observed that the level of Tbx1-GFP
protein expressed from a single allele was higher than that
observed for endogenous wildtype Tbx1. However, this
may reflect the larger domain of expression of Tbx1-GFP
within the cell lineage that is labeled by Tbx1Cre/+.
Next, we wanted to test whether Tbx1-GFP could also
rescue the cardiac defects that occur in Tbx1Cre/- em-
bryos (Figure 6A), all of which have PTA and VSD (n=3)
[12]. Analysis of Tbx1Cre/-;Tbx1GFPflox/+ embryos at E14.5
showed a complete rescue of outflow tract septation de-
fects (n=8), although 50% still had a misalignment of the
outflow tract resulting in a DORV (Figure 6B). VSD was
observed in all Tbx1Cre/-;Tbx1GFPflox/+ embryos. It is not
clear if these defects are due to failure to rescue the Tbx1
Figure 5 Dosage effects of Tbx1-GFP activation on heart development. (A) Immunofluorescence with a GFP antibody shows activation of
Tbx1-GFP by Tbx1Cre/+ at E9.5. GFP is detected in the posterior otic vesicle (OV), 1st and 2nd branchial arches (BA1, BA2), and mesoderm including
the secondary heart field proximal to the outflow tract (OFT). (B) Histological transverse sections at E14.5 shows that Tbx1Cre/+;Tbx1-GFPflox/+
mutants do not have outflow tract or ventricular defects. They survive in normal mendelian ratios, unlike Tbx1Cre/+;Tbx1-GFPflox/flox mutants which
are not viable. (C) Activation of both alleles of Tbx1-GFP by Tbx1Cre/+ causes outflow tract septation (persistant truncus arteriosis, PTA) and
alignment (double outlet right ventricle , DORV) defects with ventricular septal defect (VSD). (D) Western blot of proteins isolated from E9.5
pharyngeal regions to compare protein expression levels of Tbx1-GFP and endogenous Tbx1. For each genotype, we pooled 4 embryos
(23–24 somite stage) and loaded equal amounts of protein per lane. The same membrane was probed with antibodies to Tbx1 and β-actin.
The expected size of endogenous Tbx1 is ≈50 kD while the Tbx1-GFP fusion protein is ≈75kD. β-actin is detected at ≈40 kD.
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Tbx1-GFP protein (Figure 5D), even though protein ex-
pression levels as detected by western blot do not provide
information about the functional activity levels of Tbx1-
GFP protein. It is also possible that failure of complete
rescue is due to the fact that Tbx1-GFP is expressedconstitutively under the control of the Rosa26 promoter
and is therefore not subject to temporal regulation. Activa-
tion of both Tbx1-GFP alleles in Tbx1Cre/-; Tbx1GFPflox/flox
embryos resulted in more severe heart phenotypes includ-
ing PTA in 5/6 embryos in addition to VSD (Figure 6C)
due to further Tbx1 gene dosage imbalance.
Figure 6 Tbx1-GFP can partially rescue endogenous Tbx1Cre/- loss-of-function. Histological transverse sections through the heart at E14.5. (A)
Tbx1Cre/- mice are functionally null and have PTA and VSD. Tbx1Cre/+;Tbx1-GFPflox/+ mutants are viable with normal heart histology. (B) Tbx1Cre/-;
Tbx1-GFPflox/+ mutants exhibit complete rescue of outflow tract septation although half of the embryos have double outlet right ventricle (DORV).
(C) Tbx1Cre/-;Tbx1-GFPflox/flox mutants all have ventricular septal defect (VSD), primarily with persistant truncus arteriosus (PTA) and one example
of DORV.
Freyer et al. BMC Developmental Biology 2013, 13:33 Page 7 of 10
http://www.biomedcentral.com/1471-213X/13/33Conclusions
In summary, we have generated a new mouse model that
conditionally expresses a Tbx1-GFP fusion protein. We
show that Tbx1-GFP does not act in a dominant-
negative manner and can functionally substitute for en-
dogenous Tbx1 during heart and inner ear development
by partial rescue of heart and inner ear morphological
defects in a Tbx1Cre/- null background. We cannot com-
pletely rule out deleterious effects of the GFP tag protein
on the ability of Tbx1 to act as a transcriptional regula-
tor either via direct binding of DNA or via protein: pro-
tein interactions as we have not directly tested this.
However, ectopic activation of Tbx1-GFP by Foxg1-Cre
and Pax2-Cre causes morphological defects of the inner
ear that resemble those occurring in BAC316.23 trans-
genic mice. Taken together with the partial rescue of heart
and inner ear defects on a Tbx1−/− null background, itseems likely that the Tbx1-GFP fusion protein retains
functional characteristics of the endogenous Tbx1 protein.
As such, the Tbx1-GFP mouse line provides a genetic tool
that is amenable to probing direct downstream targets of
Tbx1 and identifying protein-protein interacting partners
of Tbx1 in vivo.
Methods
Targeting vector
A pTbx1-EGFP-N1 plasmid was generated by cloning
Tbx1 cDNA from a Tbx1-TOPO plasmid into pEGFP-
N1 (Clontech 6085–1). The following oligonucleotide
adaptor sequences were used for an in-frame ligation of
the C-terminus of Tbx1 to the N-terminus of EGFP, sim-
ultaneously changing the Tbx1 stop codon from TAG to
TTG and introducing NotI and BamHI restriction en-
zyme sites: 5’-GGCCGCGCCGCCCGGTGCCTACGAC
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AGTAGTCGTAGGCACCGGGCGGCGC-3’. Adaptors
were annealed by combining 10 nmol of each oligo-
nucleotide in 200 μL of water and heating to 90°C
followed by cooling at room temperature to 40°C. For
20 μL ligation reactions (Roche 1243292, Roche
10799009001), 5 μL of 1:500 diluted annealed adap-
tors were used. The sequence encoding the Tbx1-GFP
fusion protein was inserted into the multiple cloning
site of pBigT [13]. The loxP-tpA-loxP-Tbx1-GFP frag-
ment was excised by restriction enzyme digestion
with PacI and AscI then cloned into the pROSA26PA
plasmid [13] to generate the final targeting vector
(Figure 1). The final targeting vector was linearized
with BbvCI and purified by phenol chloroform extrac-
tion, then electroporated into WW6 ESC and selec-
tion performed with G418. Positively selected ESC
clones were plated in duplicate for DNA isolation
using the DNeasy Blood and Tissue Kit (Qiagen
69506). DNA was digested overnight at 37°C with
EcoRV and Southern blot performed with a previously
described 5’ probe [13].
Western blot
The Tbx1-GFP fusion protein was expressed in COS7
cells by transient transfection of the pTbx1-EGFP-N1
plasmid with Polyfect (Qiagen 301105). Protein from
whole cell lysate and embryonic tissue was collected
in RIPA Lysis Buffer (50 mM Tris HCl pH 7.5,
200 mM NaCl, 1% Triton X-100, 1 mM EDTA, 0.25%
deoxycholic acid, protease inhibitor). For tissue sam-
ples, the pharyngeal region was isolated from E9.5
embryos and the head, first pharyngeal arch, heart,
and caudal part of the embryos (below the fourth
pharyngeal pouch) were removed. Tissue was homog-
enized and lysed in RIPA buffer for 2 hours at 4°C.
Samples were run on 7.5 or 10% polyacrylimide gels.
Tbx1-GFP fusion protein (≈75 kD) was detected using
polyclonal anti-Tbx1 (Zymed, 1:500), anti-GFP (Invitrogen
A6455, 1:600), mouse anti-βactin (Abcam ab6276, 1:5,000),
donkey anti-Rabbit IgG-HRP (Amersham NA934V,
1:20,000) and sheep anti-Mouse IgG-HRP (Amersham
NA931V, 1:5,000) antibodies. Detection was performed
using the ECL Western Blotting Detection Kit (Amersham
RPN2106) and exposed on Kodak film.
Mouse models
Tbx1-GFP mice were genotyped with the FastStart
High Fidelity PCR System (Roche 03553361001) and
the following primers: TB3F (5’-CTGCACCACCATC
CCTACAA-3’) and GFPR (5’- TGAACTTCAGGGTC
AGCTTG-3’) for a 421 bp product from the targeted
allele, and RO1F (5’-GCAATACCTTTCTGGGAGTT-
3’) and GFP-wtR (5’- CAATGCTCTGTCTAGGGGTT-3’) for a 605 bp product from the wildtype allele.
Foxg1-Cre, Pax2-Cre, and Tbx1Cre/+ mice were kindly
provided by Drs. Jean Hebert, Andrew K. Groves,
and Antonio Baldini, respectively.. Embryos were dis-
sected according to date of vaginal plug (E0.5). Embryonic
stages <E11.5 were confirmed by counting pairs of so-
mites. Animals were maintained in a 12 hr dark/12 hr
light cycle in compliance with the Albert Einstein College
of Medicine of Yeshiva University Institutional Animal
Care and Use Committee (IACUC). Tbx1-GFP mice will
become available to the research community upon accept-
ance of the manuscript.
RNA in situ hybridization
Embryos were fixed in 4% paraformaldehyde (PFA) at
4°C overnight then dehydrated in a methanol series.
RNA in situ hybridization (ISH) was performed fol-
lowing rehydration to 0.1% PBS/0.1% Tween-20 (PBT)
[24]. Anti-sense digoxigenin-labeled RNA probe for
NeuroD [25] was generated from a plasmid by standard
protocol. The RNA probe template for netrin-1 was
generated from amplified E9.5 mouse cDNA using the




Primer sequences introduced T7 RNA polymerase
binding sites for generating antisense probes and T3
RNA polymerase binding sites for generating sense
probes. For wholemount ISH, we rehydrated embryos to
PBT and digested them with Proteinase K. This was
followed by washes in Glycine solution and PBT. Em-
bryos were then fixed in 4% PFA/0.2% gluteraldehyde for
15 min on ice followed by PBT washes. Embryos were
incubated with RNA probes in hybridization buffer
overnight at 70°C then washed in a series of SSC,
maleic acid buffer, and PBT washes. Then embryos
were incubated overnight at 4°C in antibody buffer
with 1:10,000 dilution of anti-Digoxigenin-AP antibody
(Roche 11093274910) followed by washes in 0.1% BSA/
PBT and AP1 buffer. Staining was performed using BM
Purple (Roche 11442074001) followed by fixation in 4%
PFA. RNA in situ hybridization to netrin-1 was performed
on tissue cryosections according to the David Anderson
laboratory protocol. Briefly, tissue sections were fixed
in 4% PFA for 20 min at RT and digested with Pro-
teinase K followed by post-fixation in 4% PFA for
15 min. Acetylation was performed in TEA buffer
with acetic anhydride followed by washes in PBS and
air-drying. Hybridization with RNA probes was done
overnight at 68°C in a hyb chamber humidified with
50% formamide/4X SSC. Tissue sections were washed
with SSC and PBT then incubated overnight at 4°C in
blocking buffer with 1:2,000 dilution of anti-Digoxigenin-
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and staining with BM Purple.
Immunofluorescence and whole mount
immunohistochemistry
Embryos were fixed overnight in 4% paraformaldehyde,
placed in 30% sucrose/PBS, embedded in O.C.T., then
cryosectioned at 12 μm thickness. For immunofluores-
cence, tissue sections were washed in PBS, permeabilized
for 5 min in 0.5% Triton X-100, then incubated in
blocking solution (5% serum in PBS/0.1% Triton X-100
i.e. PBT) for 1 hour. Primary antibodies (rabbit anti-
mouse pan-laminin 1:200, Chemicon AB2034; rabbit
anti-Tbx1 1:500, goat anti-GFP 1:500, Abcam ab6673)
were diluted in block and incubated on tissue for 1 hr at
room temperature. Sections were washed in PBT then
incubated with secondary antibody (Alexa Fluor 568 goat
anti-rabbit IgG 1:500; Alexa Fluor 568 donkey anti-goat
IgG 1:500) for 30 min. DAPI (1:500) was added to second-
ary antibody. Sections were washed in PBT mounted in
Vectashield hard-set mounting medium (Vector Labs
H-1400). For whole mount immunohistochemistry,
embryos were fixed overnight in 4:1 methanol/DMSO
at 4°C. Endogenous peroxidase activity was blocked in
4:1:1 methanol/DMSO/30% H2O2 for 6 hrs at room
temperature. Embryos were then rehydrated in a methanol
series and blocked in 2% milk/0.5% Triton X-100/PBS
(PBSMT) for 1 hour. Primary antibody (anti-neurofilament
1:200, DSHB mAb2H3) was diluted in PBSMT and incu-
bated overnight at 4°C. Embryos were washed five times
for an hour each in PBSMTat 4°C and then incubated with
[HRP]-sheep anti-mouse IgG (Amersham NA931V, 1:500)
diluted in PBSMT overnight at 4°C. Embryos were washed
again in PBSMT for 5 hrs at 4°C and then 30 min in 0.2%
BSA (Sigma A4503)/0.5% Triton X-100/PBS. Staining was
achieved with DAB substrate with chromagen (DAKO
K3466) for 15 min at room temperature. Embryos were
post-fixed in 4% paraformaldehyde overnight at 4°C,
dehydrated in a methanol series, then cleared in 1:2 Benzyl
alcohol: Benzyl Benzoate (BABB) for imaging and long-
term storage.
Inner ear paintfilling and histology
Embryos were sliced below the forelimbs then fixed in
5% glacial acetic acid, 2% formaldehyde, and 75% ethanol
overnight followed by an overnight dehydration in 100%
ethanol. Methyl salicylate was then used for clearing of
the tissue and long-term storage. Prior to paintfilling,
embryos were bisected dorsally and the brain was re-
moved to reveal the inner ear capsule. A micropipette
was used to microinject 0.2% correction fluid diluted in
methyl salicylate into the inner ear labyrinth. For histo-
logical analysis, embryos were fixed in 4% paraformalde-
hyde overnight at 4°C. They were then dehydrated to70% ethanol and embedded in paraffin. Tissue sectioning
was performed at 10-12 μm thickness. Tissues were
cleared in xylene, stained with hematoxylin and eosin
(H&E) and then mounted in Permount.
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